Provided by Tiger Fintech (Singapore) Pte. Ltd.

Belden

109.83
+0.35000.32%
Post-market: 109.830.00000.00%18:15 EDT
Volume:454.87K
Turnover:49.99M
Market Cap:4.34B
PE:21.24
High:110.42
Open:110.42
Low:108.90
Close:109.48
Loading ...

Belden (BDC) Receives a Rating Update from a Top Analyst

TIPRANKS
·
02 May

3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May

Motley Fool
·
02 May

Belden Reports Strong Q1 2025 Financial Results

TIPRANKS
·
02 May

Stock Track | Belden Shares Plummet 5% Despite Q1 Earnings Beat as Investors Focus on Future Outlook

Stock Track
·
02 May

Belden's Fiscal Q1 Adjusted Earnings, Revenue Rise, Q2 Outlook Set

MT Newswires Live
·
01 May

Belden Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Belden (BDC) Tops Q1 Earnings and Revenue Estimates

Zacks
·
01 May

Belden: Q1 Earnings Snapshot

Associated Press Finance
·
01 May

Belden Inc. Reports Q1 2025 Results: Sales Surge by 16.7%, Net Income Up to $51.9M, EPS Climbs to $1.27

Reuters
·
01 May

BRIEF-Belden Q1 Adjusted EPS USD 1.6 Vs. IBES Estimate USD 1.49

Reuters
·
01 May

Belden Q1 Adjusted Ebitda Margin 16.6%

THOMSON REUTERS
·
01 May

Belden Reports First Quarter 2025 Results

Business Wire
·
01 May

Rand Capital Announces $0.29 per Share Cash Dividend for Second Quarter 2025

Business Wire
·
01 May

Belden earns an impressive spot in the "Great Place to Work" Canada 2025 ranking

Business Wire
·
30 Apr

Chicago Atlantic BDC, Inc. Announces First Quarter 2025 Financial Results Conference Call

GlobeNewswire
·
30 Apr

What To Expect From Belden’s (BDC) Q1 Earnings

StockStory
·
30 Apr

Belden Inc expected to post earnings of $1.49 a share - Earnings Preview

Reuters
·
29 Apr

Golub Capital BDC Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
28 Apr

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

GlobeNewswire
·
26 Apr

Palmer Square Capital BDC Is Maintained at Overweight by JP Morgan

Dow Jones
·
25 Apr